Advancements in Cancer Hypnotherapy Research
Yuan Jia （ Shanxi Bethune Hospital, Taiyuan City, Shanxi Province, 030032,China ）
https://doi.org/10.37155/2717-5278-0501-5Abstract
Tumor cells can evade pursuit from the body's immune system through various channels, proliferating extensively within the body and causing harm to normal tissues. With the continuous development of the medical field and the cross-pollination of knowledge from various disciplines such as molecular biology, immunology, and oncology, immunotherapy has been continually refined. Adopting immunotherapy has the advantage of effectively killing tumor cells with fewer and milder side effects, leading to its increasingly widespread application. In comparison to treatments for solid tumors, the evaluation of efficacy in immunotherapy is relatively unique.
Keywords
Tumor; Immunotherapy; Immune evasion; EfficacyFull Text
PDFReferences
[2] Wang Ke, Liu Yang, Jia Zong, Wang Yi, Xie Hua, Zhou Jin. Strategies for managing primary immunotherapy-resistant complex and refractory lung cancer. [J] Cancer Prevention and Treatment, 2023, 36(12): 998-1002.
[3] Fu Hua, Wei Ying, Li Sha, Zhan Haili, Niu Bingbing, Zhang Chao. Effects of radiofrequency ablation on peripheral blood lymphocytes in liver cancer treatment. [J] Journal of Regional Surgery, 2024, 33(1): 73-76.
[4] Ren Jing, Wang Dengkui, Yang Ruina, Yuan Xiaozhi, Liu Zhiwei, Wang Xinshuai. Identification of immunotherapy-related genes in esophageal squamous cell carcinoma. [J] Diseases of the Esophagus, 2023, 5(4): 263-268.
[5] Liu Juan, Cao Xuetao. Important advances in immunology research worldwide in 2023. [J] Chinese Journal of Immunology, 2024, 40(1): 1-10.
[6] Liang Xiu, Li Jie. The value of radiotherapy in the era of immunotherapy for esophageal cancer. [J] Chinese Journal of Cancer Prevention and Treatment, 2023, 15(6): 690-695.
[7] Zhu Hongda, Yang Chaobo, Liu Yue, Zhang Zilin, Ma Kai, Guan Yeneng. Research progress on enhancing anti-tumor effects with near-infrared light-assisted immunotherapy. [J] Journal of South-Central University for Nationalities (Natural Science Edition), 2024, 43(1): 37-44.
[8] Hu Guorong, Yin Wen, Han Jieli, Xiao Yang, Hu Yi. The role of macrophages in tumor immunotherapy and its research progress. [J] Chinese Journal of Tuberculosis and Respiratory Diseases, 2024, 47(1): 75-81.
[9] Tang Shaomei, Yu Hongping, Wei Qingyi. Genetic variations/mutations of DNA mismatch repair genes and tumor treatment response. [J] Chinese Journal of Cancer Prevention and Treatment, 2023, 15(6): 593-601.
[10] Zhu Xiaojue, Jiang Yuanjing, Li Mao, Ning Bingjie, Xiong Yanli. Application of patient-reported outcomes on WeChat platform in the management of adverse reactions to tumor immunotherapy. [J] Laboratory Medicine and Clinics, 2023, 20(24): 3623-3626+3631.
[11] Gong Ying, Ailifeire Aimaiti, He Zongzhong. CD39 small molecule inhibitor ARL67156 enhances NK cell killing of gastric cancer cells. [J] Journal of Southern Medical University, 2023, 43(12): 2006-2014.
[12] Li Qian, Dai Yifei, Wei Wei. Research progress and regulatory status of neoantigen immunotherapy. [J] Chinese Journal of New Drugs, 2023, 32(24): 2483-2488.
[13] Wang Yu, Bi Nan. Advances in research on the immunomodulatory effects of radiotherapy - from basic to clinical. [J] Chinese Journal of Cancer, 2023, 33(12): 1083-1091.
Copyright © 2023 Yuan Jia
Publishing time:2023-06-30
This work is licensed under a Creative Commons Attribution 4.0 International License
Email
Location